|
|
Volumn 49, Issue 3, 1996, Pages 264-272
|
|
In Vitro and In Vivo Antibacterial Activities of a New Quinolone Derivative, Fd501
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CIPROFLOXACIN;
FD 501;
METICILLIN;
OFLOXACIN;
QUINOLONE DERIVATIVE;
SPARFLOXACIN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ANTIMICROBIAL ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
BACILLUS SUBTILIS;
BACTERICIDAL ACTIVITY;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
ESCHERICHIA COLI;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PSEUDOMONAS AERUGINOSA;
RAT;
STAPHYLOCOCCUS AUREUS;
4-QUINOLONES;
ANIMALS;
ANTI-INFECTIVE AGENTS;
CIPROFLOXACIN;
DNA TOPOISOMERASES, TYPE II;
ENZYME INHIBITORS;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
MALE;
MICROBIAL SENSITIVITY TESTS;
RATS;
RATS, SPRAGUE-DAWLEY;
|
|
EID: 0030005041
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: 10.11553/antibiotics1968b.49.264 Document Type: Article |
|
Times cited : (1)
|
|
References (11)
|
